| Ytd | -8.58% | |
| 1y | 554.08% |
| Open | 90.20 | Prev Close | 91.69 | Low | 89.24 | High | 92.66 | Mkt Cap | 4.47B |
| Vol | 374.22K | Avg Vol | 1.60M | EPS | -3.90 | P/E | -23.51 | Forward P/E | 145.38 |
| Beta | 0.16 | Short Ratio | 5.67 | Inst. Own | 95.42% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 107.70 | 200-d Avg | 102.25 | 1yr Est | 163.45 |
CELC News
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered L
Celcuity slides 15% despite FDA approval of Revtorpyk as investors focus on a late Q3 2026 launch th
NEW YORK, July 21, 2026 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of inves
NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating pot
Celcuity (NASDAQ: CELC) said the U.S. Food and Drug Administration has granted full approval to geda
NEW YORK, July 16, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors
Celcuity Inc. (CELC) Discusses FDA Approval of REVTORPYK for Advanced HR+/HER2- Breast Cancer and Co
Celcuity Inc. secured FDA approval for REVTORPYK, the first pan-PI3K, mTORC1/2 inhibitor for 2nd-lin
Gainers China Pharma Holding (AMEX:CPHI) shares moved upwards by 67.6% to $1.03 during Wednesday
Citizens analyst Silvan Turkcan maintains Celcuity (NASDAQ:CELC) with a Market Outperform and rai
Top Wall Street analysts changed outlook on top names. See all changes, including upgrades/downgrade
Shares of Celcuity fell about 8% in premarket trading on Wednesday, as the delayed commercial launch
HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Celcuity (NASDAQ:CELC) with a Bu
Celcuity NASDAQ: CELC said the U.S. Food and Drug Administration has granted full approval to gedato
MINNEAPOLIS, July 14, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a biotechnology company
Celcuity Inc. (CELC) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcr
MINNEAPOLIS, June 03, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC) ("Celcuity" or the "Comp
Celcuity (CELC) shares dropped over 25% despite Phase 3 VIKTORIA-1 data confirming gedatolisib's bes
Top Wall Street analysts changed outlook on top names. For all rating changes, upgrades and downgrad
MINNEAPOLIS, June 03, 2026 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC) ("Celcuity" or the "Comp
Celcuity Inc. (CELC) Discusses VIKTORIA-1 Trial Results for PIK3CA Mutant Advanced Breast Cancer and
Celcuity Inc. (NASDAQ:CELC) on Tuesday reported detailed efficacy and safety findings from the PIK3C
Celcuity shares slumped 25% , set for their biggest one-day decline, on Tuesday after its experiment
Global Business Travel Group Inc (GBTG), a NYSE-listed company, saw its stock rise 57% on Monday af
Wall Street analysts changed outlook on top names, including PRU, ARE, TRGP, VITL, and GOOGL. See an
Wall Street analysts upgraded and raised price targets for ESS, SITE, PKG, ABNB, and CELC. See what
Needham analyst Rick Patel maintained a Buy rating. Steven Madden shares closed at $47.27 on Friday.
eBay (NASDAQ: EBAY) rose sharply after GameStop (NYSE: GME) proposed to acquire it for $125/share, v
On Monday, 721 companies achieved new lows for the year.
On Friday, 431 companies hit new 52-week lows.
On Thursday, 112 stocks made new 52-week lows.
Before 10 a.m. ET on Tuesday, 166 companies hit new 52-week highs.
This morning 106 companies set new 52-week highs.
During the morning session on Friday, 178 stocks hit new 52-week highs.
During Thursday's morning session, 33 stocks hit new 52-week lows.
Stocks That Hit 52-Week Lows On Tuesday
Stocks That Hit 52-Week Lows On Friday
Stocks That Hit 52-Week Lows On Thursday